These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12444461)

  • 21. [Microbiological evaluation of the effectiveness of gynalgin in the treatment of vaginitis].
    Sikorski R; Hencner Z; Gliński Z; Wawrzkiewicz K; Radomański T; Milart P; Paszkowski T; Skrzypczak W; Sławiński P; Maruszak E
    Wiad Lek; 1992 Apr; 45(7-8):263-9. PubMed ID: 1462586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diversity of Bacillus thuringiensis strains isolated from citrus orchards in spain and evaluation of their insecticidal activity against Ceratitis capitata.
    Vidal-Quist JC; Castañera P; González-Cabrera J
    J Microbiol Biotechnol; 2009 Aug; 19(8):749-59. PubMed ID: 19734711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro effect of secnidazole benzoate on Trichomonas vaginalis].
    Zhang XX; Zheng SS; Zhu MM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Apr; 27(2):111-4. PubMed ID: 19856497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.
    Sobel JD; Nyirjesy P; Brown W
    Clin Infect Dis; 2001 Oct; 33(8):1341-6. PubMed ID: 11565074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of a new nitroimidazole derivative (CP 12 574) on 67 strains of T. vaginalis.
    Miltgen F; Dellenbach P; Kremer M
    Wiad Parazytol; 1973; 19(3):499-501. PubMed ID: 4542510
    [No Abstract]   [Full Text] [Related]  

  • 26. [In vitro sensitivity of 50 Trichomonas vaginalis strains to CP 12 574].
    Kremer M; Miltgen F; Dellenbach P
    Rev Fr Gynecol Obstet; 1972 Nov; 67(11):655-7. PubMed ID: 4540771
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-Trichomonas vaginalis activity of synthetic lipophilic diamine and amino alcohol derivatives.
    Giordani RB; De Almeida MV; Fernandes E; França da Costa C; De Carli GA; Tasca T; Zuanazzi JA
    Biomed Pharmacother; 2009 Sep; 63(8):613-7. PubMed ID: 19013752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of Cladonia alpestris on Trichomonas vaginalis in vitro].
    Wu J; Zhang M; Ding D; Tan T; Yan B
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):126-9. PubMed ID: 7554162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
    Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
    J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The action of an aqueous extract of Aloe barbadensis Miller in an in-vitro culture of Trichomonas vaginalis].
    Rojas L; Matamoros M; Garrido N; Finlay C
    Rev Cubana Med Trop; 1995; 47(3):181-4. PubMed ID: 9813472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo effect of 2,4-dinitro-phenyl-substituted sugar hydrazones and phenylosazone against Trichomonas vaginalis and Tritrichomonas foetus.
    Macicková T; Kettner M; Linek K
    Pharmazie; 1990 Mar; 45(3):204-6. PubMed ID: 2381964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nematocidal and trichomonacidal activities of 2-substituted quinolines.
    Martínez-Grueiro M; Giménez-Pardo C; Gómez-Barrio A; Franck X; Fournet A; Hocquemiller R; Figadère B; Casado-Escribano N
    Farmaco; 2005 Mar; 60(3):219-24. PubMed ID: 15784240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the anti-cancer-cell parasporal proteins of a Bacillus thuringiensis isolate.
    Yamashita S; Akao T; Mizuki E; Saitoh H; Higuchi K; Park YS; Kim HS; Ohba M
    Can J Microbiol; 2000 Oct; 46(10):913-9. PubMed ID: 11068678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of trichomonas infections with tinidazol in women].
    Diwald J
    Wien Med Wochenschr; 1971 Jun; 121(24):492-4. PubMed ID: 5315293
    [No Abstract]   [Full Text] [Related]  

  • 35. Arsenical pessaries in the successful elimination of metronidazole-resistant Trichomonas vaginalis.
    Watson PG; Pattman RS
    Int J STD AIDS; 1996 Jul; 7(4):296-7. PubMed ID: 8876365
    [No Abstract]   [Full Text] [Related]  

  • 36. Alternative drugs against Trichomonas vaginalis.
    Mahdi NK; Gany ZH; Sharief M
    East Mediterr Health J; 2006 Sep; 12(5):679-84. PubMed ID: 17333809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recalcitrant Trichomonas vaginalis infection--a case series.
    Waters LJ; Dave SS; Deayton JR; French PD
    Int J STD AIDS; 2005 Jul; 16(7):505-9. PubMed ID: 16004634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Trichomonacidal effect of new acridine derivatives].
    Kurnatowska A; Kadlubowski R
    Wiad Parazytol; 1973; 19(3):489-92. PubMed ID: 4542509
    [No Abstract]   [Full Text] [Related]  

  • 39. Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs.
    Marrero-Ponce Y; Meneses-Marcel A; Castillo-Garit JA; Machado-Tugores Y; Escario JA; Barrio AG; Pereira DM; Nogal-Ruiz JJ; Arán VJ; Martínez-Fernández AR; Torrens F; Rotondo R; Ibarra-Velarde F; Alvarado YJ
    Bioorg Med Chem; 2006 Oct; 14(19):6502-24. PubMed ID: 16875830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro effect of metronidazole ester on Trichomonas vaginalis and Entamoeba histolytica].
    He Y; Tao X; Guan L; Lian W
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(1):32-4. PubMed ID: 7788891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.